Panthera adapts for COVID-19 virus – Letter from Stuart Young, CEO

As we all continue to adapt to the COVID-19 pandemic, we at Panthera are closely monitoring this rapidly evolving situation as well as remaining vigilant to support our patients and the NHS in any way we can.

Panthera sites will remain open for business with significant additional precautions to prevent transmission of the COVID-19 virus.

The safety of our staff, and patients visiting our sites for essential activities, is our number one priority while we work with our clients to assess each trial to see if it can carry on in a way that is safe both for clinicians and participants.

As we continue to grow as a business, we have created fantastic environments to run clinical studies but we are also looking for ways to use our capacity to support the heroic work being done by our friends and colleagues in front-line NHS services.
Our World class team is ready to help tackle COVID-19!

Stuart Young, CEO